Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis/Experiment 1/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-25

Curated date: 2022/10/09

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland, Aiyshaaaa, Peace Sandy

Source: Supp table S3

Description: Linear discriminant analysis effect size (LDA) from phylum to species level shows differentially enriched taxa in NR and R groups. Related to Figure 4. R, response; NR, non-response.

Abundance in Group 1: decreased abundance in Responders (Partial Response or Stable Disease)

NCBI	Quality Control	Links
Acidaminococcaceae
Acidaminococcales
Acidaminococcus
Alistipes
Bilophila
Desulfovibrionaceae
Desulfovibrionales
Desulfovibrionia
Fusobacteriaceae
Fusobacteriales
Fusobacteriia
Fusobacteriota
Fusobacterium
Fusobacterium sp.
Lachnoclostridium
Marinifilaceae
Oscillospiraceae
Rikenellaceae
Thermodesulfobacteriota
unclassified Acidaminococcus
unclassified Alistipes
uncultured Bilophila sp.

Revision editor(s): Mary Bearkland, Aiyshaaaa, Peace Sandy